Beta blockers and long-term outcome after coronary artery bypass grafting: a nationwide observational study.
Martin LindgrenSusanne J NielsenErik BjörklundAldina PivodicSossio PerrottaEmma C HanssonAnders JeppssonAndreas MartinssonPublished in: European heart journal. Cardiovascular pharmacotherapy (2022)
Ongoing treatment with cardioselective beta blockers after CABG is associated with a reduction in MACEs, mainly because of reduced long-term risk for MI. The association between cardioselective beta blockers and MI was consistent in patients with and patients without previous MI, heart failure, atrial fibrillation, or reduced LVEF.
Keyphrases
- coronary artery bypass grafting
- heart failure
- atrial fibrillation
- percutaneous coronary intervention
- angiotensin converting enzyme
- end stage renal disease
- coronary artery disease
- chronic kidney disease
- peritoneal dialysis
- angiotensin ii
- left ventricular
- left atrial
- left atrial appendage
- venous thromboembolism
- catheter ablation
- direct oral anticoagulants
- patient reported